HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Raffaele Costanzo Selected Research
Raffaele Costanzo Research Topics
Disease
16
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2020 - 02/2008
11
Neoplasms (Cancer)
10/2022 - 03/2014
6
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2022 - 08/2014
3
Brain Neoplasms (Brain Tumor)
01/2022 - 01/2006
2
Circulating Neoplastic Cells
01/2022 - 11/2012
2
Adenocarcinoma of Lung
01/2022 - 05/2013
2
Disease Progression
01/2022 - 07/2013
2
Lung Neoplasms (Lung Cancer)
07/2020 - 10/2019
2
Hemorrhage
01/2020 - 01/2016
2
Fatigue
01/2018 - 04/2010
2
Adenocarcinoma
09/2017 - 01/2016
1
Melanoma (Melanoma, Malignant)
10/2022
1
Necrosis
02/2021
1
Neoplasm Metastasis (Metastasis)
02/2021
1
Breast Neoplasms (Breast Cancer)
02/2021
1
Anorexia
01/2018
1
Diarrhea
01/2016
1
Hypertension (High Blood Pressure)
01/2016
1
Renal Insufficiency (Renal Failure)
01/2016
1
Carcinoma (Carcinomatosis)
08/2014
1
Vomiting
02/2008
1
Neutropenia
02/2008
1
Cardiotoxicity
03/2005
1
Atrial Fibrillation
03/2005
1
Familial primary gastric lymphoma
03/2005
1
Muscular Dystrophies (Muscular Dystrophy)
03/2005
1
Cardiac Arrhythmias (Arrythmia)
03/2005
1
Myotonic Dystrophy (Dystrophia Myotonica)
03/2005
1
Lymphoma (Lymphomas)
07/2004
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
07/2004
Drug/Important Bio-Agent (IBA)
5
Platinum
IBA
09/2020 - 07/2013
5
Cisplatin (Platino)
FDA Link
Generic
01/2018 - 07/2013
4
ErbB Receptors (EGF Receptor)
IBA
01/2020 - 01/2011
4
Gemcitabine
FDA Link
03/2014 - 02/2008
4
Gefitinib (Iressa)
FDA Link
01/2014 - 01/2011
3
Erlotinib Hydrochloride (CP 358,774)
FDA Link
01/2022 - 01/2014
3
Tyrosine Kinase Inhibitors
IBA
01/2014 - 01/2011
2
Angiogenesis Inhibitors
IBA
01/2021 - 01/2020
2
Proteins (Proteins, Gene)
FDA Link
01/2021 - 08/2014
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2021 - 01/2014
2
pembrolizumab
IBA
09/2020 - 10/2019
2
Bevacizumab (Avastin)
FDA Link
01/2020 - 01/2014
2
nintedanib
IBA
09/2017 - 01/2016
2
Docetaxel (Taxotere)
FDA Link
09/2017 - 01/2016
2
Enzymes
IBA
01/2016 - 04/2010
2
Pemetrexed (MTA)
FDA Link
03/2014 - 04/2010
2
Paclitaxel (Taxol)
FDA Link
Generic
04/2010 - 02/2008
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
10/2022
1
Trabectedin
IBA
01/2022
1
Cell-Free Nucleic Acids
IBA
01/2022
1
PM 01183
IBA
01/2022
1
Bleomycin (Blenoxane)
FDA Link
Generic
02/2021
1
Nivolumab
IBA
09/2020
1
atezolizumab
IBA
07/2020
1
Monoclonal Antibodies
IBA
07/2020
1
Ramucirumab
IBA
01/2020
1
B7-H1 Antigen
IBA
10/2019
1
Etoposide (VP 16)
FDA Link
Generic
01/2017
1
Afatinib
IBA
01/2016
1
Creatinine
IBA
01/2016
1
Carboplatin (JM8)
FDA Link
Generic
01/2016
1
Cystatin C
IBA
01/2016
1
Small Interfering RNA (siRNA)
IBA
08/2014
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
10/2013
1
Keratin-7 (Cytokeratin 7)
IBA
05/2013
1
Cetuximab (Erbitux)
FDA Link
02/2012
1
Temozolomide (Temodar)
FDA Link
Generic
01/2006
1
liposomal doxorubicin (Doxil)
FDA Link
01/2006
1
Doxorubicin (Adriamycin)
FDA Link
Generic
03/2005
1
Oxaliplatin (Eloxatin)
FDA Link
Generic
07/2004
1
Rituximab (Mabthera)
FDA Link
07/2004
Therapy/Procedure
10
Drug Therapy (Chemotherapy)
10/2022 - 07/2004
5
Therapeutics
01/2022 - 07/2013
2
Immunotherapy
10/2022 - 09/2020
1
Palliative Care (Palliative Therapy)
02/2021
1
General Anesthesia
02/2021
1
Segmental Mastectomy (Lumpectomy)
02/2021
1
Radical Mastectomy
02/2021
1
Mastectomy (Mammectomy)
02/2021
1
Intravenous Infusions
01/2020
1
Radiotherapy
01/2017